Preclinical research shows that targeting the IL1RAP protein can disrupt an inflammatory network that shields pancreatic tumors, reducing fibrosis and suppressor cells while enhancing T cell activity — a strategy that could make chemotherapy and immunotherapy more effective.
Blocking IL1RAP May Break Pancreatic Cancer's Protective Shield
Preclinical research shows that targeting the IL1RAP protein can disrupt an inflammatory network that shields pancreatic tumors, reducing fibrosis and suppressor cells while enhancing T cell activity — a strategy that could make chemotherapy and immunotherapy more effective.
Pancreatic cancer · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.